You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
A National Academies of Sciences, Engineering, and Medicine report recommends that the attempt to revise the Common Rule start over again, NPR reports.
Six US agencies made Thomson Reuters' list of most innovative government research institutions.
Dozens of government agencies, academic institutions, and a various public and private sector organizations have now committed to driving the initiative forward.
A GAO review finds no evidence of disparities in grant success rates by gender at agencies with sufficient data, but some agencies are not conducting required Title IX compliance reviews.
The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.
The agency is specifically aiming to fund the development of diagnostics for pandemic influenza, as well as biological, radiological, and nuclear agents.
HHS has filed an application with the USPTO to service mark the moniker "precision medicine initiative" and distinguish the government effort from other projects.
The contract is to further the company's work to develop methodologies aimed at Francisella tularensis, Escherichia coli, and Babesia microti.
Applied Biosystems (Life Technologies) has been awarded US Patent No. 8,572,506, "Visualization tool for qPCR genotyping data."
Gordon Janaway and Evelyn Wing-Sim Chan are named as inventors.
NEW YORK (GenomeWeb News) – With the two houses of the US Congress failing to reach a budget deal and inching the federal government closer to a likely shutdown, agencies are scrambling to prepare and notifying employees of furloughs.
Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.
NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.
Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.
In Science this week: review discusses advances in liquid biopsies, and more.